Article ID Journal Published Year Pages File Type
5565198 Complementary Therapies in Medicine 2017 7 Pages PDF
Abstract
LOR of Remicade occurs when IL-1 increases, and it can cause malignancy. Research shows Curcumin reduces IL-1 and improves cancer outcomes. Future research, using both Remicade and Curcumin, would have to be done, but preliminary data would suggest using both would reduce LOR. Curcumin, even by itself, was found to be a cheap and safe way to reduce CD symptoms and inflammatory markers.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Complementary and Alternative Medicine
Preview
Comparison of remicade to curcumin for the treatment of Crohn's disease: A systematic review
Authors
, , , ,